Some published studies have reported that SEC61G may serve as a prognostic indicator in different types of cancer, including glioblastoma (GBM), hepatocellular carcinoma (HCC), and kidney cancer. The gene discussed is SEC61G; the disease is hepatocellular carcinoma.